Celcuity (CELC) – Trading Halts
-
Celcuity (CELC) Halted on LUDP
-
Celcuity (CELC) Reports Preliminary Data from Phase 1b Trial of Gedatolisib plus Ibrance and Endocrine Therapy for Patients with ER+/HER2- Metastatic Breast Cancer and Provides Corporate Update
-
-
Back to CELC Stock Lookup